AttackMS

Testing the safety and efficacy of natalizumab very early in MS. Evidence suggests this will give MS patients a better long-term outcome.

[AttackMS @AttackMS_trial]

We’re pleased to share that we have enrolled our first participant since reopening!

Thank you to our dedicated site teams for their hard work.

If you know individuals who may be interested in learning more about the study, please contact [email protected]

[AttackMS @AttackMS_trial]

Attack is back!

Thank you to the MS Register for a well-written blog post that is great reminder of how AttackMS could impact the nearly 7,000 people per year diagnosed with the disease in the UK.

Check out the blog post below ⤵️

https://t.co/kK3G7VVwH6
@KlausSchmierer

[AttackMS @AttackMS_trial]

#AttackMS has officially reopened 🎉

If you or your patient meets the criteria below, please contact [email protected]!

[Klaus Schmierer @KlausSchmierer]

📢#AttackMS Recruitment SUSPENDED until further notice. Enrolled participants are safe. Email [email protected] remains open "Don't despair: despair suggests you are in total control and know what's coming. You don't – surrender to events with hope" (Alain de Botton)🤞

[AttackMS @AttackMS_trial]

Fantastic new tool to help MS patients navigate life during this time of long waits for NHS services, developed by a member of the #AttackMS team @AndreaStennett 👏👏👏
AttackMS participants have fast access to treatment - we hope everyone will one day soon!

[Klaus Schmierer @KlausSchmierer]

🔥 The #BartsMSNavigator Now on the @NHSBartsHealth website: https://t.co/f2d1nfTxPm Thank you all #Team11D, and particularly @AndreaStennett @Kimberley_AP @joelamathews👏

A #BartsMS #Navigator https://t.co/jD1JfLDE8k @the_MSBlog

[AttackMS @AttackMS_trial]

2 new participants enrolled today! 🥳 #AttackMS participants are diagnosed and start treatment within 2 weeks, compared to many months wait with the current NHS pathway. Congratulations to @RoyalLondonHosp @NHSBartsHealth @ChelwestFT @KlausSchmierer

[AttackMS @AttackMS_trial]

More evidence to support the AttackMS early treatment approach #AttackMS

Early multiple sclerosis treatment may lead to less disability https://t.co/FZnniUcWXA

[AttackMS @AttackMS_trial]

Please help us spread the word #AttackMS Trial of a highly effective treatment within 14 days of first symptom(s) Contact [email protected] @MSTrust @mssocietyuk @shiftms @MSUK6 @mssociety

[Klaus Schmierer @KlausSchmierer]

Let's get #AttackMS trending @AttackMS_trial Highly effective treatment trial within 14 days of first symptom(s) Contact [email protected] from *anywhere* in the #UK Ask your doctor @StGeorgesTrust @ChelwestFT @NHSBartsHealth @Wendybird2012 @themsguide @RachelHorne19

[AttackMS @AttackMS_trial]

AttackMS is working to show why prompt treatment is needed to help people live well with MS. We're looking for participants with possible MS symptoms in the last 14 days. Get in touch: [email protected]

[Klaus Schmierer @KlausSchmierer]

📢#AttackMS If rapid access pathways are axed, the goal of living with #MS but #NotFeelMS is under threat @AttackMS_trial: Symptoms suggestive of MS within past 14 days? Up to 45 years old? Contact [email protected] @ChelwestFT @StGeorgesTrust @shiftms @NHSBartsHealth

[AttackMS @AttackMS_trial]

Why has the AttackMS trial been suggested to me?
Hear from Wendy and Dom @themsguide about what the trial involves

https://t.co/pegnrpDbFi

[Klaus Schmierer @KlausSchmierer]

Is ProfK trying to do the impossible, getting people a rapid diagnosis AND on treatment within two weeks of symptom onset? https://t.co/5MseRmfRHX

[MSTrust @MSTrust]

Diagnosing #MS can be a lengthy procedure, and getting on a treatment path can take even longer. So what happens when you treat potential MS really early?

In this episode, we talk to @KlausSchmierer & @RachelHorne19 about the AttackMS trial.

Listen now

https://t.co/ck8cPPXwM6